文献速递头颈部肿瘤放疗

放射性口干与干细胞剂量依赖性唾液分泌减少相关

Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-04-15

在570例接受根治性放疗的头颈癌患者中,前瞻性测量放疗前、放疗后6个月和12个月时的腮腺及颌下/舌下腺流量与患者报告的口干。线性混合效应模型显示,腮腺干细胞富集区平均剂量(Dmean,SCR)通过降低腮腺流量影响日间口干,支持临床实施干细胞保护性放疗以保留唾液流。

要点

  • 腮腺干细胞富集区平均剂量是腮腺流量下降的原因,非干细胞富集区剂量不影响腮腺流量。
  • Dmean,SCR每增加10 Gy,放疗后腮腺流量减少0.02 mL/min(25%),日间口干评分升高2.13分(5%)。
  • 颌下腺平均剂量每增加10 Gy,颌下/舌下腺流量减少0.07 mL/min(26%),夜间口干评分升高2.20分(6%)。

核心结论

  • 较高的干细胞富集区剂量降低腮腺唾液分泌,进而导致日间口干评分升高。
  • 本研究支持临床实施干细胞保护性放疗以保留唾液流,旨在降低口干风险。

研究设计与样本

  • 前瞻性研究,纳入570例接受根治性放疗的头颈癌患者。
  • 在放疗前、放疗后6个月和12个月测量腮腺及颌下/舌下腺流量,以及患者报告的日间和夜间口干。
  • 使用线性混合效应模型分析各唾液腺及口腔平均剂量与唾液流和口干的关系,并校正已知混杂因素。

主要发现

  • Dmean,SCR是腮腺平均剂量对腮腺流量影响的 responsible 因素(P ≤ .03),而非干细胞富集区腮腺组织剂量不影响腮腺流量(P ≥ .11)。
  • 在固定非干细胞富集区剂量下,Dmean,SCR增加10 Gy使放疗后腮腺流量减少0.02 mL/min(25%);反之则腮腺流量无变化(0.00 mL/min [4%])。
  • 颌下腺平均剂量与颌下/舌下腺流量显著相关(P < .001),每增加10 Gy使放疗后流量减少0.07 mL/min(26%)。
  • Dmean,SCR和口腔平均剂量与较高的日间口干评分相关(P ≤ .05),颌下腺平均剂量增加夜间口干评分(P = .01)。
  • 腮腺流量仅影响日间口干(P < .001,每1 mL/min唾液对应日间口干评分降低10.92分),颌下/舌下腺流量影响日间和夜间口干(P ≤ .004,每1 mL/min唾液分别降低6.69和5.74分)。

关键数值与推荐

  • Dmean,SCR增加10 Gy(固定非干细胞富集区剂量)使放疗后腮腺流量减少0.02 mL/min(25%)。
  • Dmean,sub增加10 Gy使放疗后颌下/舌下腺流量减少0.07 mL/min(26%)。
  • Dmean,SCR增加10 Gy使放疗后日间口干评分升高2.13分(5%)。
  • Dmean,sub增加10 Gy使放疗后夜间口干评分升高2.20分(6%)。
  • 每1 mL/min腮腺流量对应日间口干评分降低10.92分(P < .001);每1 mL/min颌下/舌下腺流量对应日间和夜间口干评分分别降低6.69和5.74分(P ≤ .004)。

临床怎么用

  • 本研究支持临床实施干细胞保护性放疗以保留唾液流,旨在降低口干风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Previous studies have shown that the mean dose to the parotid gland stem cell rich regions (Dmean,SCR) is the strongest dosimetric predictor for the risk of patient-reported daytime xerostomia. This study aimed to test whether the relationship between patient-reported xerostomia and Dmean,SCR is explained by a dose-dependent reduction of saliva production. METHODS AND MATERIALS: In 570 patients with head and neck cancer treated with definitive radiation therapy (RT), flow from the parotid (FLOWPAR) and submandibular/sublingual (FLOWSMSL) glands, and patient-reported daytime (XERDAY) and nighttime (XERNIGHT) xerostomia were prospectively measured before, at 6 months, and 12 months after RT. Using linear mixed effect models, the relationship of the mean dose to the parotid glands (Dmean,par), Dmean,SCR, non-SCR parotid gland tissue (Dmean,non-SCR), submandibular glands (Dmean,sub), and oral cavity (Dmean,oral) with salivary flow and xerostomia was analyzed while correcting for known confounders. RESULTS: Dmean,SCR proved to be responsible for the effect of Dmean,par on FLOWPAR (P ≤ .03), while Dmean,non-SCR did not affect FLOWPAR (P ≥ .11). To illustrate, increasing Dmean,SCR by 10 Gy at a fixed Dmean,non-SCR reduced FLOWPAR by 0.02 mL/min (25%) after RT. However, if the opposite happened, no change in FLOWPAR was observed (0.00 mL/min [4%]). As expected, Dmean,sub was significantly associated with FLOWSMSL (P < .001). For example, increasing Dmean,sub by 10 Gy reduced FLOWSMSL by 0.07 mL/min (26%) after RT. Xerostomia scores were also affected by dose to the salivary glands. Dmean,SCR and Dmean,oral were associated with higher XERDAY scores (P ≤ .05), while Dmean,sub increased XERNIGHT scores (P = .01). For example, an increase of 10 Gy in Dmean,SCR raised XERDAY scores by 2.13 points (5%) after RT, while an additional 10 Gy in Dmean,subs increased XERNIGHT scores by 2.20 points (6%) after RT. Salivary flow was not only associated with radiation dose, but also with xerostomia scores in line with the salivary glands' functions; ie, FLOWPAR only influenced XERDAY (P < .001, 10.92 points lower XERDAY per 1 mL/min saliva), while FLOWSMSL affected XERDAY and XERNIGHT (P ≤ .004, 6.69 and 5.74 points lower XERDAY and XERNIGHT, respectively, per 1 mL/min saliva). Therefore, the observed relationships between dose and xerostomia were corrected for salivary flow. As hypothesized, Dmean,SCR only increased XERDAY scores via reducing FLOWPAR, whereas the effects of Dmean,oral on XERDAY and Dmean,sub on XERNIGHT were independent of salivary flow. CONCLUSIONS: Higher SCR region dose reduced parotid gland saliva production, subsequently resulting in higher daytime xerostomia scores. Consequently, this study supports the clinical implementation of stem cell sparing RT to preserve salivary flow with the aim of reducing the risk of xerostomia.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. van Rijn-Dekker MI, la Bastide-van Gemert S, Stokman MA, et al. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production. Int J Radiat Oncol Biol Phys. 2024. PMID: 38631537. doi:10.1016/j.ijrobp.2024.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。